H.C. Wainwright Downgrades Rapt Therapeutics (RAPT) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY

6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Price: $58.02 --0%

Rating Summary:
7 Buy, 13 Hold, 0 Sell

Rating Trend: Down

Down

Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0

H.C. Wainwright analyst Emily Bodnar downgraded Rapt Therapeutics (NASDAQ: RAPT) from Buy to Neutral with a price target of $58.00.

For an analyst ratings summary and ratings history on Rapt Therapeutics click here. For more ratings news on Rapt Therapeutics click here.

Shares of Rapt Therapeutics closed at $35.10 yesterday.

Downgrades

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!